• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION MOSAIC ULTRA PORCINE HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION MOSAIC ULTRA PORCINE HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number 305U2J
Device Problem Material Rupture (1546)
Patient Problems Congestive Heart Failure (1783); Hemolysis (1886)
Event Date 06/20/2016
Event Type  Injury  
Manufacturer Narrative
Additional information was requested, regarding the exact implant duration and the patient's demographic information.No further in formation was provided.Please note, the device implant date is an estimate.If additional information is received, a supplemental report will be submitted.
 
Event Description
Medtronic received information that approximately five years post implant of this bioprosthetic valve, this product was explanted and replaced.Upon explant, a tear was identified at the commissures between the right coronary cusp and non coronary cusp as well as between the right coronary cusp and left coronary cusp.The patient's symptoms prior to the replacement procedure include heart failure and hemolysis.No other adverse patient effects were reported.
 
Manufacturer Narrative
Product analysis: upon receipt at medtronic¿s quality laboratory, the returned product specimen was visually examined.The valve was rotated in the stent, with the right cusp of the valve to the non-coronary cusp position in the stent.Per manufacturing procedures, depending on the structure of the porcine tissue, a valve may be rotated to accommodate the appropriate fit to the stent.All leaflets were slightly stiff but flexible except where host tissue and/or mineralization extend on the inflow and/or outflow.Tissue deterioration due to mineralization was observed on all leaflets.A small tear observed on the non-coronary cusp adjacent to the right non-coronary commissure appeared to be associated with explant.The non-coronary left commissure appeared to be intact.Tissue deterioration due to mineralization was observed on the left right and right non-coronary commissures.Remnants of pannus remained attached to the tissue and base stitching adjacent to all existing cusps, extending into all inferior coaptive areas, and 1 to 3 mm onto all existing cusps showing a reduced inflow orifice area.Remnants of pannus remained attached to the existing sewing ring on the outflow, extending to the backs of all stent posts and outflow rail adjacent to the right cusp.An unknown amount of pannus appeared to have been removed on the inflow and outflow during explant.Radiography showed mineralization in all leaflets and two commissures.Conclusion: the device history record was reviewed and showed that this product met all manufacturing specifications for product released for distribution.No issues were identified that would have impacted this event.Based on the received information and the returned product analysis, the observed calcification could have potentially caused the tissue deterioration / cuspal tear.Calcification has been an inherent risk of surgical valve replacement.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information that approximately five years post implant of this bioprosthetic valve, this product was explanted and replaced with a competitor's valve.Upon explant, a tear was identified at the commissures between the right coronary cusp and non coronary cusp as well as between the right coronary cusp and left coronary cusp.The patient's symptoms prior to the replacement procedure include heart failure and hemolysis.No other adverse patient effects were reported.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MOSAIC ULTRA PORCINE HEART VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key5788255
MDR Text Key49362135
Report Number2025587-2016-01029
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P990064
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 10/05/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/09/2015
Device Model Number305U2J
Device Catalogue Number305U2J23
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/10/2016
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/21/2016
Initial Date FDA Received07/12/2016
Supplement Dates Manufacturer ReceivedNot provided
10/05/2016
Supplement Dates FDA Received10/10/2016
09/24/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/09/2010
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-